NMD Part 3 Flashcards
what are 2 types of neuropathies
spinal muscular atrophy (SMA)
charcot-marie tooth dz
what is SMA
genetic dz that causes progressive degeneration of motor neurons in SC
- & brainstem in severe cases
results in progressive ms weakness d/t denervation
what is the inheritance pattern of SMA
autosomal-recessive
- aka both parents need to be carriers)
what are SMN1’s role
involved in maintenance of anterior horn cells
what is the leading cause of death in infancy
SMA
before spinraza in 2016
what is the pathophys of SMA
most common form d/t to defect in survival motor neuron 1 (SMN1) gene
how is severity of SMA reflected in pathophys of dz
more severe - SMN1 gene depleted
less severe - SMN2 gene present in great numbers
- more preserved motor function and less disability
how is severe anterior horn cell loss in SMA reflected in ms
atrophic fibers
- islands of group hypertrophy
what are the classic signs of SMA
tongue fasciculations
resting hand tremors
if clinical findings suggest a SMA dx, what is the next step
this is a red flag
- stop and decide if more urgent or emergent referral
either way will generate referral for genetic testing
what are 5 clinical findings/red flags seen in dx SMA
- hypotonia and weakness (LE>UE)
- delayed onset of head control, or loss of motor skills in early childhood
- absent DTRs
- tongue fasciculations*
- resting hand tremors*
what is the SMA classification system defined by
phenotypic classification defined by:
- age of sx onset
- max function achieved
what are the 3 SMA types per their max function achieved
type I = nonsitters
- never achieve ability to sit (I)
type 2 = sitters
- achieve sitting, but not walking
type 3 = walkers
- walk (I) at some point but may lose function (as degeneration progresses)
prognosis of untreated SMA type 1 and why
fatal in early childhood
- respiratory dz
what is the age of sx onset for SMA type 1
0-3mo
are there any signs of type 1 SMA in utero
mothers have noted dec activity of fetus in utero in last weeks before birth
how are social/cognitive skills impacted in SMA
seemingly spared in all 3 types
what is the greatest functional ability that defines SMA 1
defined by inability to sit independently
how does weakness present in type 1 SMA
weakness greatest in prox ms
- progressively worsens
most never develop head control
what are the goals of rehab techniques in type 1 SMA
positional and palliative
- stretching, comfort, positioning
what is the onset of sx of type 2 SMA
12-18mo
what is the life expectancy for type 2 SMA
most survive to 5yo
fewer, but still majority survive to 25yo
what are the functional capabilities of SMA type 2 and how does this change
ability to sit independently
- lose ability over time
never walk independently
what are the 5 impairments/sx seen in type 2
fatigue
progressive ms weakness
joint contractures
scoliosis
pulmonary dz
when is type 3 SMA dx
12-18mo to 3yo
- type 3a dx <3yo
- type 3b dx >3yo
what is the life expectancy of SMA type 3
normal
what are the functional abilities of SMA type 3
able to amb independently w/o AD
loss of amb during adolescence w/o treatment
what are 4 impairments seen in type 3 SMA
- mild UE weakness noted initially but will decline
- post tib ms, hamstrings, and hip flexor tightness
- scoliosis d/t postural compensations & ms weakness
- fatigue
what are 5 medical interventions for SMA
respiratory care
wt management
surgery
liquid albuterol
meds to change dz course
what types of SMA is respiratory care implemented in and how
type 1 and 2
- biPAP for some at night
- daily cough assist/suctioning
why is wt management a relevant medical intervention for SMA and what types is this most relevant in
aides movement
- in type 1 and 2, easier for them to move and for us to move them
what surgeries are seen in SMA and what are the indications for them
scoliosis
hip sublux/dislocation
optimizes:
- lung function
- sitting balance
- decrease pain
why is liquid albuterol a relevant intervention for SMA
can inc energy levels during day
what are the 2 main types of meds that can change the course of SMA
spinraza
gene therapy (zolgensma, evrysdi)